| 2017-03-06 | Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease | Kang, Seo Young; Lee, Sang-Bin; Kim, Hee Ju; Kim, Hee-Tae; Yang, Hyun Ok; Jang, Wooyoung |
| 2014-01-01 | Development of lipidomic platform and phosphatidylcholine retention time index for lipid profiling of rosuvastatin treated human plasma | Choi, Jong Min; Kim, Tae-Eun; Cho, Joo-Youn; Lee, Hwa Jeong; Jung, Byung Hwa |
| - | Lipid biomarker candidates from rosuvastatin-treated human plasma using lipidomic platform | Choi Jong min; Lee Hwa Jung; Jung, Byung Hwa |
| - | Lipidomic approach to study metabolic changes in oral administration of rosuvastatin in both healthy human and hypercholesterolemic patients | Choi Jong min; Lee Hwa Jeong; Jung, Byung Hwa |
| 2018-08 | Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics | Lee, Hyunbeom; Choi, Jong Min; Cho, Joo-Youn; Kim, Tae-Eun; Lee, Hwa Jeong; Jung, Byung Hwa |
| 2017-09 | The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-Density Lipoprotein | Kim, Tae-Eun; Shin, Dongseong; Gu, Namyi; Jung, Byung Hwa; Kim, Jayoun; Cho, Young Min; Yu, Kyung-Sang; Cho, Joo-Youn |
